The growing epidemic of antibiotic resistance necessitates a fast, patient-centered care solution that enables providers to make timely, informed treatment decisions. PCR tests for many pathogen targets as well as antibiotic resistant targets while traditional culture based testing reveals only a small number of pathogens. BMD offers providers access to the most advanced molecular methodology for pathogen detection, quantification, and resistance gene identification, empowering them to more quickly and effectively treat revealed pathogens while avoiding adverse drug events. The result is quicker patient recovery and reduced readmission rates as well as prevention of pathogen outbreaks in long term care facilities.